Research Initiative
Collaboration
Title
Collaboration
Type
HHS Participating Agencies
NIH Participating Institutes/ Centers/ Office of the Director
Year Collaboration Originated
Details
Observational Cohort to Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance following Initiation of Tenofovir-Lamivudine-Dolutegravir (TLD)
Research Initiative
CDC
NIAID
2018
Occupational Exposure Assessment of Emerging Per- and Polyfluoroalkyl Substances (PFAS)
Research Initiative
CDC
NIEHS
2020
Operation Warp Speed (OWS)
Research Initiative
CDC, FDA, ASPR
NIAID
2020
Funding levels reported in the Fiscal Year 2020 Intra-Agency Collaborations Reporting System (CRS) may not be consistent with funding levels reported under the Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) at the NIH Office of Budget Website at
http://report.nih.gov/categorical_spending.aspx
. The current process, implemented in 2008 through the Research, Condition, and Disease Categorization (RCDC) system, uses sophisticated text data mining (categorizing and clustering using words and multiword phrases) in conjunction with NIH-wide definitions used to match projects to categories. RCDC use of data mining improves consistency and eliminates the wide variability in defining the research categories reported. The definitions are a list of terms and concepts selected by NIH scientific experts to define a research category. The research category levels represent the NIH’s best estimates based on the category definitions.